cupure logo

New cancer treatment could 'change the world' for newly diagnosed head and neck cancer patients by adding several years to their life

New cancer treatment could 'change the world' for newly diagnosed head and neck cancer patients by adding several years to their life
During a major phase III trial, pembrolizumab combined with standard treatment kept cancer at bay for an average of 60 months - five years - compared to the typical 30 months.

Comments

Breaking news